2016
$215M
from 11 investors over 11 rounds
Arbor Biotechnologies raised $215M on November 9, 2021
Investors: TCG X, Tao Capital Partners, Surveyor Capital, Tekla Capital Management, T. Rowe Price, Section 32, Vertex Pharmaceuticals, Temasek, Ridgeback Capital Management LLC and Woodline Partners LP
Arbor Biotechnologies raised $16M on June 1, 2017
Investors: ARCH Venture Partners